Quantum Pharmaceutical

Durham, United Kingdom Founded: 2004 • Age: 22 yrs Acquired By Clinigen
Unlicensed medicines are manufactured for various applications.

About Quantum Pharmaceutical

Quantum Pharmaceutical is a Healthcare company based in Durham (United Kingdom) founded in 2004, and was acquired by Clinigen in December 2017. Unlicensed medicines are manufactured for various applications. Quantum Pharmaceutical offers products and services including Unlicensed Medicines and Hard-to-Source Products. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Quantum Pharmaceutical Limited.

Company details

Quantum Pharmaceutical was established in 2004 in Durham, United Kingdom, within the pharmaceutical sector. Unlicensed medicines are produced by the company, focusing on specialized formulations not covered by standard regulatory approvals. Operations are managed from the UK base, with Andrew Matthews serving as Managing Director. Distribution and services target niche medical needs across the region.

  • Headquarters Durham, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website quantumpharmaceutical.co.uk
  • Social LinkedIn X
  • Acquired by Clinigen (Dec 2017)
  • Legal Name Quantum Pharmaceutical Limited
Key Metrics
  • Annual Revenue
    $147.15 M (USD)
    -1
    as on Dec 31, 2022
  • Net Profit
    $16.27 M (USD)
    120
    as on Dec 31, 2023
  • Latest Funding Round
    $18.43M (USD), Post-IPO

    Oct 2016

  • Investors
    Clinigen

    & 1 more

  • Acquired by
    Clinigen

    & 1 more

    (Dec 2017)

Products & Services of Quantum Pharmaceutical

Quantum Pharmaceutical offers a comprehensive portfolio of products and services, including Unlicensed Medicines and Hard-to-Source Products.

Unlicensed Medicines
Pharmaceutical Products

Unlicensed medicines are manufactured and supplied for various uses in healthcare settings

Hard-to-Source Products
Supply Services

Hard-to-source products are distributed and made available through sourcing and delivery processes

Funding Insights of Quantum Pharmaceutical

  • Total Rounds 1
  • Last Round Post-IPO β€” $18.43M
  • First Round $18.43M

    (Oct 2016)

All 1 funding rounds of Quantum Pharmaceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2016$18.43MPost-IPO––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Quantum Pharmaceutical

Quantum Pharmaceutical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Clinigen and LDC.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments are focused on multiple sectors for growth.
1981ldc.co.ukLondon, United Kingdom
Specialty medicines are supplied via clinical trials and access programs.
2010clinigengroup.comBurton-on-trent, United Kingdom
Premium access

Investor details for Quantum Pharmaceutical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Quantum Pharmaceutical

1 people are tracked at Quantum Pharmaceutical (1 in leadership).

NameRoleGroup
Andrew Matthews
Managing DirectorLeadership
Premium access

Complete people profiles for Quantum Pharmaceutical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Quantum Pharmaceutical

4 dated milestones of Quantum Pharmaceutical across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quantum Pharmaceutical is founded.
  2. Exit Acquired by LDC.
  3. Funding First funding round of $18.4M.
  4. Exit Acquired by Clinigen.

Web traffic of Quantum Pharmaceutical

The website of Quantum Pharmaceutical (quantumpharmaceutical.co.uk) receives about 3.5K visits a month.

  • Monthly visits
    3.5K

    ▼ 25.4% vs previous month

Similar websites

Websites whose visitors overlap most with Quantum Pharmaceutical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
steroidpharmacy.co.uk
steroidpharmacy.co.uk
100%
#6,750,565–
quanta-pharma.com
quanta-pharma.com
89%
#2,216,042–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Quantum Pharmaceutical

Quantum Pharmaceutical was founded in 2004 and raised its 1st funding round 12 years after it was founded.

Quantum Pharmaceutical is headquartered in Durham, United Kingdom.

Annual revenue of Quantum Pharmaceutical is $147.15M as on Dec 31, 2022.

Quantum Pharmaceutical was established in 2004 in Durham, United Kingdom, within the pharmaceutical sector. Unlicensed medicines are produced by the company, focusing on specialized formulations not covered by standard regulatory approvals. Operations are managed from the UK base, with Andrew Matthews serving as Managing Director. Distribution and services target niche medical needs across the region.

Quantum Pharmaceutical offers Unlicensed Medicines and Hard-to-Source Products.

Quantum Pharmaceutical has 2 investors. Key investors include Clinigen, and LDC.

Quantum Pharmaceutical operates through Quantum Pharmaceutical Limited.

Yes. Quantum Pharmaceutical was acquired by Clinigen in December 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available